Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$44.36 USD
-0.18 (-0.40%)
Updated Sep 10, 2024 03:59 PM ET
After-Market: $44.38 +0.02 (0.05%) 6:00 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
- YR Estimate
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- 12/31/2018
- Revenue - Line of Business (LOBR)
- Net revenues: Total finished pharmaceutical products net revenues
- 486.51
- 419.57
- 331.37
- 302.00
- --
- Revenue - Line of Business (LOBR)
- Net revenues: API (Active pharmaceutical ingredients)
- 12.48
- 18.20
- 18.48
- 20.36
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Glucagon
- 55.32
- 47.64
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Primatene MIST
- 84.31
- 73.11
- 51.73
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Epinephrine
- 74.20
- 57.53
- 23.80
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Lidocaine
- 52.54
- 44.41
- 41.11
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Enoxaparin
- 34.95
- 35.96
- 48.68
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Phytonadione
- 49.50
- 45.50
- 42.65
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Naloxone
- 26.27
- 27.54
- 33.42
- --
- --
- Revenue - Line of Business (LOBR)
- Net revenues: Other finished pharmaceutical products
- 109.41
- 87.88
- 89.99
- --
- --